PubMed:26582609 / 794-1129 JSONTXT

{"project":"Glycan-Motif","denotations":[{"id":"T3","span":{"begin":272,"end":279},"obj":"https://glytoucan.org/Structures/Glycans/G00021MO"},{"id":"T4","span":{"begin":272,"end":279},"obj":"https://glytoucan.org/Structures/Glycans/G54161DR"},{"id":"T5","span":{"begin":306,"end":317},"obj":"https://glytoucan.org/Structures/Glycans/G43702JT"}],"text":"In this study, several differentially oligomerizing chemokines (CCL2, CCL3, CCL5, CCL7, CXCL4, CXCL8, CXCL11 and CXCL12) and select oligomerization-deficient mutants were systematically characterized by surface plasmon resonance to determine their relative affinities for heparin, heparan sulfate (HS) and chondroitin sulfate-A (CS-A)."}

{"project":"GlyCosmos6-Glycan-Motif-Image","denotations":[{"id":"T3","span":{"begin":272,"end":279},"obj":"Glycan_Motif"},{"id":"T5","span":{"begin":306,"end":317},"obj":"Glycan_Motif"}],"attributes":[{"id":"A3","pred":"image","subj":"T3","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR"},{"id":"A4","pred":"image","subj":"T3","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO"},{"id":"A5","pred":"image","subj":"T5","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G43702JT"}],"text":"In this study, several differentially oligomerizing chemokines (CCL2, CCL3, CCL5, CCL7, CXCL4, CXCL8, CXCL11 and CXCL12) and select oligomerization-deficient mutants were systematically characterized by surface plasmon resonance to determine their relative affinities for heparin, heparan sulfate (HS) and chondroitin sulfate-A (CS-A)."}

{"project":"GlyCosmos6-Glycan-Motif-Structure","denotations":[{"id":"T3","span":{"begin":272,"end":279},"obj":"https://glytoucan.org/Structures/Glycans/G00021MO"},{"id":"T4","span":{"begin":272,"end":279},"obj":"https://glytoucan.org/Structures/Glycans/G54161DR"},{"id":"T5","span":{"begin":306,"end":317},"obj":"https://glytoucan.org/Structures/Glycans/G43702JT"}],"text":"In this study, several differentially oligomerizing chemokines (CCL2, CCL3, CCL5, CCL7, CXCL4, CXCL8, CXCL11 and CXCL12) and select oligomerization-deficient mutants were systematically characterized by surface plasmon resonance to determine their relative affinities for heparin, heparan sulfate (HS) and chondroitin sulfate-A (CS-A)."}

{"project":"sentences","denotations":[{"id":"TextSentencer_T7","span":{"begin":0,"end":335},"obj":"Sentence"},{"id":"T7","span":{"begin":0,"end":335},"obj":"Sentence"},{"id":"T7","span":{"begin":0,"end":335},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In this study, several differentially oligomerizing chemokines (CCL2, CCL3, CCL5, CCL7, CXCL4, CXCL8, CXCL11 and CXCL12) and select oligomerization-deficient mutants were systematically characterized by surface plasmon resonance to determine their relative affinities for heparin, heparan sulfate (HS) and chondroitin sulfate-A (CS-A)."}

{"project":"Glycosmos6-GlycoEpitope","denotations":[{"id":"T1","span":{"begin":281,"end":296},"obj":"http://www.glycoepitope.jp/epitopes/EP0086"},{"id":"T2","span":{"begin":298,"end":300},"obj":"http://www.glycoepitope.jp/epitopes/EP0086"},{"id":"T3","span":{"begin":306,"end":317},"obj":"http://www.glycoepitope.jp/epitopes/EP0081"}],"text":"In this study, several differentially oligomerizing chemokines (CCL2, CCL3, CCL5, CCL7, CXCL4, CXCL8, CXCL11 and CXCL12) and select oligomerization-deficient mutants were systematically characterized by surface plasmon resonance to determine their relative affinities for heparin, heparan sulfate (HS) and chondroitin sulfate-A (CS-A)."}

{"project":"GlycoBiology-FMA","denotations":[{"id":"_T60","span":{"begin":52,"end":62},"obj":"FMAID:241980"},{"id":"_T61","span":{"begin":52,"end":62},"obj":"FMAID:241985"},{"id":"_T62","span":{"begin":52,"end":62},"obj":"FMAID:241984"},{"id":"_T63","span":{"begin":52,"end":62},"obj":"FMAID:241981"},{"id":"_T64","span":{"begin":52,"end":62},"obj":"FMAID:241982"},{"id":"_T65","span":{"begin":52,"end":62},"obj":"FMAID:241983"},{"id":"_T66","span":{"begin":203,"end":210},"obj":"FMAID:50594"},{"id":"_T67","span":{"begin":203,"end":210},"obj":"FMAID:146300"},{"id":"_T68","span":{"begin":272,"end":279},"obj":"FMAID:167420"},{"id":"_T69","span":{"begin":272,"end":279},"obj":"FMAID:82839"},{"id":"_T70","span":{"begin":281,"end":288},"obj":"FMAID:67110"},{"id":"_T71","span":{"begin":281,"end":288},"obj":"FMAID:165191"},{"id":"_T72","span":{"begin":281,"end":296},"obj":"FMAID:167405"},{"id":"_T73","span":{"begin":281,"end":296},"obj":"FMAID:63023"},{"id":"_T74","span":{"begin":306,"end":325},"obj":"FMAID:196838"},{"id":"_T75","span":{"begin":306,"end":325},"obj":"FMAID:82837"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"In this study, several differentially oligomerizing chemokines (CCL2, CCL3, CCL5, CCL7, CXCL4, CXCL8, CXCL11 and CXCL12) and select oligomerization-deficient mutants were systematically characterized by surface plasmon resonance to determine their relative affinities for heparin, heparan sulfate (HS) and chondroitin sulfate-A (CS-A)."}

{"project":"uniprot-human","denotations":[{"id":"T1","span":{"begin":64,"end":68},"obj":"http://www.uniprot.org/uniprot/P13500"},{"id":"T2","span":{"begin":70,"end":74},"obj":"http://www.uniprot.org/uniprot/P10147"},{"id":"T3","span":{"begin":76,"end":80},"obj":"http://www.uniprot.org/uniprot/P13501"},{"id":"T4","span":{"begin":82,"end":86},"obj":"http://www.uniprot.org/uniprot/P80098"},{"id":"T5","span":{"begin":88,"end":93},"obj":"http://www.uniprot.org/uniprot/P02776"},{"id":"T6","span":{"begin":95,"end":100},"obj":"http://www.uniprot.org/uniprot/Q9UCR9"},{"id":"T7","span":{"begin":102,"end":108},"obj":"http://www.uniprot.org/uniprot/O14625"},{"id":"T8","span":{"begin":113,"end":119},"obj":"http://www.uniprot.org/uniprot/Q6ICW0"},{"id":"T9","span":{"begin":329,"end":331},"obj":"http://www.uniprot.org/uniprot/O75390"}],"text":"In this study, several differentially oligomerizing chemokines (CCL2, CCL3, CCL5, CCL7, CXCL4, CXCL8, CXCL11 and CXCL12) and select oligomerization-deficient mutants were systematically characterized by surface plasmon resonance to determine their relative affinities for heparin, heparan sulfate (HS) and chondroitin sulfate-A (CS-A)."}

{"project":"GlycoBiology-NCBITAXON","denotations":[{"id":"T10","span":{"begin":38,"end":51},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/441291"},{"id":"T11","span":{"begin":38,"end":51},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/265229"},{"id":"T12","span":{"begin":132,"end":147},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/265229"},{"id":"T13","span":{"begin":132,"end":147},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/441291"}],"text":"In this study, several differentially oligomerizing chemokines (CCL2, CCL3, CCL5, CCL7, CXCL4, CXCL8, CXCL11 and CXCL12) and select oligomerization-deficient mutants were systematically characterized by surface plasmon resonance to determine their relative affinities for heparin, heparan sulfate (HS) and chondroitin sulfate-A (CS-A)."}

{"project":"GO-BP","denotations":[{"id":"T4","span":{"begin":289,"end":296},"obj":"http://purl.obolibrary.org/obo/GO_0051923"},{"id":"T5","span":{"begin":318,"end":325},"obj":"http://purl.obolibrary.org/obo/GO_0051923"}],"text":"In this study, several differentially oligomerizing chemokines (CCL2, CCL3, CCL5, CCL7, CXCL4, CXCL8, CXCL11 and CXCL12) and select oligomerization-deficient mutants were systematically characterized by surface plasmon resonance to determine their relative affinities for heparin, heparan sulfate (HS) and chondroitin sulfate-A (CS-A)."}

{"project":"GlycoBiology-Motifs","denotations":[{"id":"T2","span":{"begin":272,"end":279},"obj":"http://rdf.glycoinfo.org/glycan/G54161DR"},{"id":"T5","span":{"begin":306,"end":317},"obj":"http://rdf.glycoinfo.org/glycan/G00018MO"},{"id":"T6","span":{"begin":306,"end":325},"obj":"http://rdf.glycoinfo.org/glycan/G00018MO"}],"text":"In this study, several differentially oligomerizing chemokines (CCL2, CCL3, CCL5, CCL7, CXCL4, CXCL8, CXCL11 and CXCL12) and select oligomerization-deficient mutants were systematically characterized by surface plasmon resonance to determine their relative affinities for heparin, heparan sulfate (HS) and chondroitin sulfate-A (CS-A)."}

{"project":"GlycoBiology-Epitope","denotations":[{"id":"PD-GlycoEpitope-B_T1","span":{"begin":306,"end":317},"obj":"http://www.glycoepitope.jp/epitopes/EP0081"},{"id":"PD-GlycoEpitope-B_T2","span":{"begin":281,"end":296},"obj":"http://www.glycoepitope.jp/epitopes/EP0086"}],"text":"In this study, several differentially oligomerizing chemokines (CCL2, CCL3, CCL5, CCL7, CXCL4, CXCL8, CXCL11 and CXCL12) and select oligomerization-deficient mutants were systematically characterized by surface plasmon resonance to determine their relative affinities for heparin, heparan sulfate (HS) and chondroitin sulfate-A (CS-A)."}

{"project":"mondo_disease","denotations":[{"id":"T1","span":{"begin":329,"end":333},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0019569"}],"text":"In this study, several differentially oligomerizing chemokines (CCL2, CCL3, CCL5, CCL7, CXCL4, CXCL8, CXCL11 and CXCL12) and select oligomerization-deficient mutants were systematically characterized by surface plasmon resonance to determine their relative affinities for heparin, heparan sulfate (HS) and chondroitin sulfate-A (CS-A)."}

{"project":"Glycan-GlyCosmos","denotations":[{"id":"T1","span":{"begin":306,"end":317},"obj":"Glycan"},{"id":"T3","span":{"begin":281,"end":296},"obj":"Glycan"},{"id":"T2","span":{"begin":298,"end":300},"obj":"Glycan"}],"attributes":[{"id":"A1","pred":"glycosmos_id","subj":"T1","obj":"https://glycosmos.org/glycans/show/G43702JT"},{"id":"A4","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G43702JT"},{"id":"A2","pred":"image","subj":"T3","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW"},{"id":"A3","pred":"image","subj":"T2","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW"}],"text":"In this study, several differentially oligomerizing chemokines (CCL2, CCL3, CCL5, CCL7, CXCL4, CXCL8, CXCL11 and CXCL12) and select oligomerization-deficient mutants were systematically characterized by surface plasmon resonance to determine their relative affinities for heparin, heparan sulfate (HS) and chondroitin sulfate-A (CS-A)."}

{"project":"GlyCosmos15-MONDO","denotations":[{"id":"T1","span":{"begin":329,"end":333},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0019569"}],"text":"In this study, several differentially oligomerizing chemokines (CCL2, CCL3, CCL5, CCL7, CXCL4, CXCL8, CXCL11 and CXCL12) and select oligomerization-deficient mutants were systematically characterized by surface plasmon resonance to determine their relative affinities for heparin, heparan sulfate (HS) and chondroitin sulfate-A (CS-A)."}

{"project":"sentences","denotations":[{"id":"TextSentencer_T7","span":{"begin":0,"end":335},"obj":"Sentence"},{"id":"T7","span":{"begin":0,"end":335},"obj":"Sentence"},{"id":"T7","span":{"begin":0,"end":335},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In this study, several differentially oligomerizing chemokines (CCL2, CCL3, CCL5, CCL7, CXCL4, CXCL8, CXCL11 and CXCL12) and select oligomerization-deficient mutants were systematically characterized by surface plasmon resonance to determine their relative affinities for heparin, heparan sulfate (HS) and chondroitin sulfate-A (CS-A)."}

{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T7","span":{"begin":0,"end":335},"obj":"Sentence"}],"text":"In this study, several differentially oligomerizing chemokines (CCL2, CCL3, CCL5, CCL7, CXCL4, CXCL8, CXCL11 and CXCL12) and select oligomerization-deficient mutants were systematically characterized by surface plasmon resonance to determine their relative affinities for heparin, heparan sulfate (HS) and chondroitin sulfate-A (CS-A)."}

{"project":"GlyCosmos15-Glycan","denotations":[{"id":"T1","span":{"begin":306,"end":317},"obj":"Glycan"},{"id":"T3","span":{"begin":281,"end":296},"obj":"Glycan"},{"id":"T2","span":{"begin":298,"end":300},"obj":"Glycan"}],"attributes":[{"id":"A1","pred":"glycosmos_id","subj":"T1","obj":"https://glycosmos.org/glycans/show/G43702JT"},{"id":"A4","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G43702JT"},{"id":"A2","pred":"image","subj":"T3","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW"},{"id":"A3","pred":"image","subj":"T2","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G17927IW"}],"text":"In this study, several differentially oligomerizing chemokines (CCL2, CCL3, CCL5, CCL7, CXCL4, CXCL8, CXCL11 and CXCL12) and select oligomerization-deficient mutants were systematically characterized by surface plasmon resonance to determine their relative affinities for heparin, heparan sulfate (HS) and chondroitin sulfate-A (CS-A)."}

{"project":"GlyCosmos15-GlycoEpitope","denotations":[{"id":"T1","span":{"begin":281,"end":296},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T2","span":{"begin":298,"end":300},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T3","span":{"begin":306,"end":317},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"}],"attributes":[{"id":"A1","pred":"glycoepitope_id","subj":"T1","obj":"http://www.glycoepitope.jp/epitopes/EP0086"},{"id":"A2","pred":"glycoepitope_id","subj":"T2","obj":"http://www.glycoepitope.jp/epitopes/EP0086"},{"id":"A3","pred":"glycoepitope_id","subj":"T3","obj":"http://www.glycoepitope.jp/epitopes/EP0081"}],"text":"In this study, several differentially oligomerizing chemokines (CCL2, CCL3, CCL5, CCL7, CXCL4, CXCL8, CXCL11 and CXCL12) and select oligomerization-deficient mutants were systematically characterized by surface plasmon resonance to determine their relative affinities for heparin, heparan sulfate (HS) and chondroitin sulfate-A (CS-A)."}

{"project":"GlyCosmos-GlycoEpitope","denotations":[{"id":"T1","span":{"begin":281,"end":296},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T2","span":{"begin":298,"end":300},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T3","span":{"begin":306,"end":317},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"}],"attributes":[{"id":"A1","pred":"glycoepitope_id","subj":"T1","obj":"http://www.glycoepitope.jp/epitopes/EP0086"},{"id":"A2","pred":"glycoepitope_id","subj":"T2","obj":"http://www.glycoepitope.jp/epitopes/EP0086"},{"id":"A3","pred":"glycoepitope_id","subj":"T3","obj":"http://www.glycoepitope.jp/epitopes/EP0081"}],"text":"In this study, several differentially oligomerizing chemokines (CCL2, CCL3, CCL5, CCL7, CXCL4, CXCL8, CXCL11 and CXCL12) and select oligomerization-deficient mutants were systematically characterized by surface plasmon resonance to determine their relative affinities for heparin, heparan sulfate (HS) and chondroitin sulfate-A (CS-A)."}